Your account is not claimed yet. You can sign up with ORCID to claim your account.

Stefano Parodi

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Cancers

International journal of molecular sciences

Pediatric blood & cancer

Oncoimmunology

Istituto Giannina Gaslini

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Giannina Gaslini Mar 15o 2017

Italy

Untenured researcher :: Epidemiology and Biostatistics Unit

Publications

Marzia Ognibene, Patrizia de Marco, Loredana Amoroso, Martina Fragola, Federico Zara, Stefano Parodi, Annalisa Pezzolo
Neuroblastoma Patients' Outcome and Chromosomal Instability. International journal of molecular sciences 24 (21) (2023)
Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Marzia Ognibene, Annalisa Pezzolo, Roberto Cavanna, Davide Cangelosi, Stefania Sorrentino, Stefano Parodi
A Simple, Test-Based Method to Control the Overestimation Bias in the Analysis of Potential Prognostic Tumour Markers. Cancers 15 (4) (2023)
Marzia Ognibene, Patrizia de Marco, Loredana Amoroso, Davide Cangelosi, Federico Zara, Stefano Parodi, Annalisa Pezzolo
Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis. Cancers 15 (7) (2023)
Marzia Ognibene, Patrizia De Marco, Stefano Parodi, Mariaclaudia Meli, Andrea Di Cataldo, Federico Zara, Annalisa Pezzolo
Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4. International journal of molecular sciences 23 (12) (2022)
Marzia Ognibene, Davide Cangelosi, Stefania Sorrentino, Sabrina Zanardi, Federico Zara, Annalisa Pezzolo, Stefano Parodi
E2F3 gene expression is a potential negative prognostic marker for localised and MYCN not-amplified neuroblastoma: Results of in silico analysis of 786 samples. Pediatric blood & cancer 69 (10) (2022)
Alberto Garaventa, Stefano Parodi, Giulia Guerrini, Piero Farruggia, Alessandra Sala, Marta Pillon, Salvatore Buffardi, Francesca Rossi, Maurizio Bianchi, Marco Zecca, Luciana Vinti, Elena Facchini, Tommaso Casini, Sayla Bernasconi, Loredana Amoroso, Salvatore D'Amico, Massimo Provenzi, Raffaela De Santis, Antonella Sau, Paola Muggeo, Rosa Maria Mura, Riccardo Haupt, Maurizio Mascarin, Roberta Burnelli
Outcome of Children and Adolescents with Recurrent Classical Hodgkin Lymphoma: The Italian Experience. Cancers 14 (6) (2022)
Marzia Ognibene, Loredana Amoroso, Fraia Melchionda, Davide Cangelosi, Federico Zara, Stefano Parodi, Annalisa Pezzolo
High Grade of Amplification of Six Regions on Chromosome 2p in a Neuroblastoma Patient with Very Poor Outcome: The Putative New Oncogene TSSC1. Cancers 13 (22) (2021)
Shigeyuki Nakaji, Kazushige Ihara, Kaori Sawada, Stefano Parodi, Takashi Umeda, Ippei Takahashi, Koichi Murashita, Shizuka Kurauchi, Itoyo Tokuda
Social innovation for life expectancy extension utilizing a platform-centered system used in the Iwaki health promotion project: A protocol paper. SAGE open medicine 9 (2021)
Paola Manduca, Nabil Al Baraquni, Stefano Parodi
Long Term Risks to Neonatal Health from Exposure to War-9 Years Long Survey of Reproductive Health and Contamination by Weapon-Delivered Heavy Metals in Gaza, Palestine. International journal of environmental research and public health 17 (7) (2020)
Stefano Parodi, Angela Pistorio, Giovanni Erminio, Marzia Ognibene, Martina Morini, Alberto Garaventa, Anna Rita Gigliotti, Riccardo Haupt, Francesco Frassoni, Annalisa Pezzolo
Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile. Pediatric blood & cancer 66 (5) (2019)
Stefano Parodi, Corrado Dosi, Antonella Zambon, Enrico Ferrari, Marco Muselli
Identifying Environmental and Social Factors Predisposing to Pathological Gambling Combining Standard Logistic Regression and Logic Learning Machine. Journal of gambling studies 33 (4) (2018)
Fabio Morandi, Loredana Amoroso, Alessandra Dondero, Roberta Castriconi, Stefano Parodi, Roberto Luksch, Fiorina Casale, Aurora Castellano, Alberto Garaventa, Alessandro Moretta, Cristina Bottino, Mirco Ponzoni, Maria Valeria Corrias
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma. Oncoimmunology 7 (9) (2018)

Stefano Parodi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stefano Parodi